NCT02935205 2023-11-29Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate CancerUniversity of California, DavisPhase 1/2 Unknown38 enrolled
NCT02849990 2022-01-13A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomyUniversity of WashingtonPhase 2 Completed22 enrolled 11 charts